Ftse Mib
35.090,23
-0,64%
DAX
20.214,79
-0,51%
S&P 500
5.827,04
-1,54%
NASDAQ
19.161,63
-1,63%
Bitcoin
94.122,75
-0,62%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Collegium Pharmaceutical Inc (COLL) Collegium Pharmaceutical Inc (COLL) Notizie

Collegium Pharmaceutical Inc

COLL
32,91
-0,43 (-1,29%)
11 Gen 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
10/1/202522:14EDGAR2Form 144 - Report of proposed sale of securities
08/1/202514:05EDGAR2Form 8-K - Current report
08/1/202514:00GLOBECollegium Provides 2025 Financial Guidance and Business..
14/11/202422:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/11/202422:49EDGAR2Form 3 - Initial statement of beneficial ownership of..
12/11/202414:00GLOBECollegium to Participate in Upcoming Investor Conferences
07/11/202422:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202422:02GLOBECollegium Reports Record Third Quarter 2024 Financial..
07/11/202422:01EDGAR2Form 8-K - Current report
07/11/202422:01GLOBECollegium Appoints Vikram Karnani as Chief Executive Officer
24/10/202414:00GLOBECollegium to Report Third Quarter 2024 Financial Results on..
17/9/202422:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/9/202416:39EDGAR2Form 144 - Report of proposed sale of securities
13/9/202416:06EDGAR2Form 144 - Report of proposed sale of securities
06/9/202423:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/9/202417:53EDGAR2Form 144 - Report of proposed sale of securities
05/9/202422:47EDGAR2Form 144 - Report of proposed sale of securities
04/9/202414:03EDGAR2Form 8-K - Current report
30/8/202414:00GLOBECollegium to Participate in H.C. Wainwright 26th Annual..
28/8/202414:00GLOBECollegium Announces Eight Poster Presentations at PAINWeek..
15/8/202422:05EDGAR2Form S-8 - Securities to be offered to employees in employee..
12/8/202420:41EDGAR2Form 144 - Report of proposed sale of securities
09/8/202422:34EDGAR2Form 144 - Report of proposed sale of securities
08/8/202422:04EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202422:01EDGAR2Form 8-K - Current report
08/8/202422:01GLOBECollegium Reports Second Quarter 2024 Financial Results
29/7/202412:02EDGAR2Form 8-K - Current report
29/7/202412:00GLOBECollegium to Acquire Ironshore Therapeutics, Expanding into..
25/7/202414:00GLOBECollegium to Report Second Quarter 2024 Financial Results on..
13/6/202414:05EDGAR2Form 8-K - Current report
13/6/202414:00GLOBECollegium Obtains Six Month Extension of U.S. Pediatric..
05/6/202422:50EDGAR2Form 144 - Report of proposed sale of securities
05/6/202422:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/6/202422:36EDGAR2Form 144 - Report of proposed sale of securities
03/6/202423:22EDGAR2Form 144 - Report of proposed sale of securities
03/6/202419:59EDGAR2Form 144 - Report of proposed sale of securities
30/5/202419:11EDGAR2Form 144 - Report of proposed sale of securities
29/5/202417:19EDGAR2Form 144/A - Report of proposed sale of securities: [Amend]
29/5/202416:05EDGAR2Form 144 - Report of proposed sale of securities
29/5/202414:00GLOBECollegium to Participate in Jefferies Global Healthcare..
28/5/202422:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/5/202418:12EDGAR2Form 144 - Report of proposed sale of securities
28/5/202416:05EDGAR2Form 144 - Report of proposed sale of securities
24/5/202422:05EDGAR2Form 8-K - Current report
24/5/202419:01EDGAR2Form 144 - Report of proposed sale of securities
23/5/202422:22EDGAR2Form 144 - Report of proposed sale of securities
20/5/202422:05EDGAR2Form 8-K - Current report
17/5/202401:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/5/202401:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/5/202401:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 33,50 Min: 32,40 Max: 33,89
Chiusura: 33,34

La tua Cronologia

NASDAQ
COLL
Collegium Pharmaceutical
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network